Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. - Wikidata - awgldk - TriplyDB

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

http://www.wikidata.org/entity/Q30656679

about

Immunosuppressive agents for treating IgA nephropathy Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy Functional characterization and expression analysis of members of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family from Drosophila melanogaster.Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.O-linked glycosylation determines the nephritogenic potential of IgA rheumatoid factor.DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease The genetics and immunobiology of IgA nephropathy.Genetic studies of IgA nephropathy: past, present, and future.Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease.Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation.Down-regulation of core 1 beta1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1.Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function.Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.Disruption of Smad4 expression in T cells leads to IgA nephropathy-like manifestations.Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy.Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy.Development of Animal Models of Human IgA Nephropathy Uncoupling of glomerular IgA deposition and disease progression in alymphoplasia mice with IgA nephropathy Specificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice O-glycosylated IgA rheumatoid factor induces IgA deposits and glomerulonephritis.Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery.Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression

P2860

Q24188035-4A6065C0-160A-456B-9A17-5C3A59D84D40 Q24319005-32C7E22D-777F-4208-A493-57EDF963A26A Q24680134-AAC36F3D-E0D0-4FD3-B672-1A87D6C69CFA Q26751472-5049194C-491B-4190-9204-B70B73623569 Q26752555-2A2A6443-94FB-4281-AE46-94E8E178550C Q26782025-AF619F0F-3902-4441-93A6-71B085CFE2BC Q28539595-120DDB86-FF2A-4249-BB7B-75D558C57FCF Q30954205-3F5DB31A-C8BE-45C6-B1DC-1C06946376DC Q33597457-D19EA0CA-8F46-49D0-8CB6-4436ECD04D38 Q33654763-F9A4EAA2-16BA-41D9-AA95-094D847FA160 Q33660620-DDF294FF-85F1-4C25-AAD5-C2C48447DD4A Q33740666-811D8B60-5ECF-4286-A15B-DE5AD4C5D110 Q33872517-13647B67-D470-4415-B781-6DDDAC63F6FB Q34109845-7871DA99-C53A-4468-BEF8-4329A1BD4C73 Q34126171-E0BA943E-4B64-4B2C-BD5D-8689D35CA88E Q34320745-88F449CB-274D-4874-AAB1-7A2497AA6D0C Q34340715-138A82AA-5BC5-4E1D-924B-DC0CE8CA46AD Q34468379-974640B0-B530-4D4E-8290-B7D0D314E209 Q34557198-05A03A1F-BF8F-42DF-9444-CB18E93D4263 Q34579691-87FD0CFD-2057-4457-B448-DEFCBBD6B749 Q34608317-AC108F86-6345-464B-B4EB-0CD02E965E3F Q34655605-022A0632-F902-4E4C-BAAF-82C4966903B9 Q34655791-A7B39067-EC0D-49E5-AEB8-9FAAC3596880 Q34869928-66BC2A2F-C279-4DE8-8C39-80C980816DB6 Q35022256-F64D6ACC-75CA-4FB6-B2D9-A23E956CEA63 Q35041026-15F9C980-FB0D-4405-A420-052C4E9C2895 Q35101639-6B0940C1-A801-4ED4-A20C-1D54B6EE6795 Q35107938-9361C887-2791-4FDD-A9A8-A3DECCAF5786 Q35110061-5E6A2EB4-6551-4792-B79F-21473E0AACDD Q35151900-03BAD99D-DAF0-4153-9FA7-9BE3F6013274 Q35225422-39D2E161-A8FE-443A-85B0-A7F19FA9C132 Q35468711-47CF2EC9-6BC0-40D7-91E2-A229C7661ABB Q35750178-C13DDF51-FFDC-4BD9-B0BC-479A957531A3 Q35804190-C661F868-6907-4FA4-BFF7-A193EBC12470 Q35886028-3D29E5D8-E9A2-47EF-AAA4-84A649034A80 Q35917473-88BE9489-2BE0-4ACF-8EF5-94819B58E1BC Q36184802-F34BB728-411E-4F31-833D-FBAA895F9709 Q36199715-F450794D-676C-4832-A4B6-A25F3D6732EF Q36200922-A0B445BD-7FD7-41D4-BA44-6B1706182E0F Q36237466-DE37C4D4-E953-4E61-AE86-E77098FBB9E8

P2860

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

http://www.wikidata.org/entity/Q30656679

description

2001 nî lūn-bûn

@nan

2001 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մարտին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

@ast

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

@en

type

label

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

@ast

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

@en

prefLabel

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

@ast

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

@en

P1433

Q30656679-E655FB76-5094-48CD-AA66-7EAF597DDF96

P1476

Q30656679-AD81610A-A0C4-4758-B7CB-0486CF5F3B3F

P2093

Q30656679-23CC223E-A0A7-47FE-A4E8-04E06C48174D

Q30656679-3A7E2604-F707-4A73-92D2-9697FFEF029A

Q30656679-3B0EC80A-E3EA-4313-8074-EE6D0F25F165

Q30656679-670660CA-4069-4709-B72A-8FEFF4990DFF

Q30656679-8FA68C52-D604-4598-A7DA-6F588D1A2FEF

Q30656679-ABA36002-EC40-4DE1-BEDC-36C89B7F5AE6

Q30656679-D8F36D7F-7376-4531-BB44-19FBF0FAEB1A

Q30656679-E2E66B84-9F20-4F0E-BB1F-760741B47ACA

Q30656679-ED76909C-6220-4BB2-ABB3-F01A946D2D58

P2888

Q30656679-B75552C9-F81D-4A2D-9CF1-89A01B23499C

P304

Q30656679-C79C77CD-A3EF-42CB-BD7C-1A2CA0FA5DB5

P31

Q30656679-D4BC16E9-DF64-49C4-A08A-09A244F5D312

P356

Q30656679-3B23E383-8F9A-4CB9-A750-DA7A3F1F9158

P407

Q30656679-8DDC2BB3-A4EF-4DD0-A71F-A56ABB1F6272

P433

Q30656679-EE96E35F-4122-4FBB-82C4-9D49DA941CD6

P478

Q30656679-E2A17B40-97F7-4F9E-932E-E035D313888E

P577

Q30656679-4A1AF43E-4914-4702-A283-D5D4FA8C01DA

P5875

Q30656679-ACEBA688-D328-4DBE-8B28-E788BC31400C

P6179

Q30656679-A56B9D0E-7B13-4E9F-8047-D780418CA1B8

P698

Q30656679-5F7CED61-0532-4D42-9307-02A88D00A894

P921

Q30656679-A74115F1-6A88-43B0-85EC-7DD9094AE57E

P356

J.1523-1755.2001.0590031077.X

P1433

Kidney International

P1476

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

@en

P2093

Hiki Y

http://www.w3.org/2001/XMLSchema#string

Iwase H

http://www.w3.org/2001/XMLSchema#string

Kobayashi Y

http://www.w3.org/2001/XMLSchema#string

Maeda K

http://www.w3.org/2001/XMLSchema#string

Nishimoto A

http://www.w3.org/2001/XMLSchema#string

Odani H

http://www.w3.org/2001/XMLSchema#string

Shinzato T

http://www.w3.org/2001/XMLSchema#string

Takahashi M

http://www.w3.org/2001/XMLSchema#string

Yasuda Y

http://www.w3.org/2001/XMLSchema#string

P2888

j.1523-1755.2001.0590031077.x

P304

1077-1085

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1523-1755.2001.0590031077.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2001-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12101115

http://www.w3.org/2001/XMLSchema#string

P6179

1001417712

http://www.w3.org/2001/XMLSchema#string

P698

11231363

http://www.w3.org/2001/XMLSchema#string

P921